| Glauco Radoslovich, MD | |
|
20 Prospect Ave, Ste 701, Hackensack, NJ 07601-1997 | |
| (201) 996-2997 | |
| (201) 996-2571 |
| Full Name | Glauco Radoslovich |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 39 Years |
| Location | 20 Prospect Ave, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598732935 | NPI | - | NPPES |
| 2101549 | Other | NJ | GHI PPO |
| BS504 | Other | NJ | OXFORD |
| 81061 | Other | NJ | AMERIGROUP |
| 000000120940 | Other | NJ | GHI HMO |
| 02868633 | Medicaid | NY | |
| 4545953 | Other | NJ | AETNA PPO |
| 2307025 | Other | NJ | AETNA HMO |
| 5387906 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0001X | Internal Medicine - Clinical Cardiac Electrophysiology | 25MA0575800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Good Samaritan Hospital Of Suffern | Suffern, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Englewood Pc | 1355512252 | 519 |
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, and Dialysis Corporation of America, a leading provider of outpatient kidney dialysis centers, announced today that they have entered into a definitive merger agreement for USRC to acquire DCA.
Primary care physicians should focus on "dementia red flags" rather than routinely screen individuals with no dementia symptoms just because they've reached a certain age, according to Malaz Boustani, M.D., MPH, of the Indiana University School of Medicine and the Regenstrief Institute, Inc. and colleagues from the University of Kent and the University of Cambridge in the United Kingdom in a commentary published in the Nov. 28 issue of the Journal of the American Medical Association.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.
› Verified 2 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, and Dialysis Corporation of America, a leading provider of outpatient kidney dialysis centers, announced today that they have entered into a definitive merger agreement for USRC to acquire DCA.
Primary care physicians should focus on "dementia red flags" rather than routinely screen individuals with no dementia symptoms just because they've reached a certain age, according to Malaz Boustani, M.D., MPH, of the Indiana University School of Medicine and the Regenstrief Institute, Inc. and colleagues from the University of Kent and the University of Cambridge in the United Kingdom in a commentary published in the Nov. 28 issue of the Journal of the American Medical Association.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.
› Verified 2 days ago
| Entity Name | Humc Cardiovascular Partners, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417188905 PECOS PAC ID: 6406996503 Enrollment ID: O20091222000199 |
News Archive
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, and Dialysis Corporation of America, a leading provider of outpatient kidney dialysis centers, announced today that they have entered into a definitive merger agreement for USRC to acquire DCA.
Primary care physicians should focus on "dementia red flags" rather than routinely screen individuals with no dementia symptoms just because they've reached a certain age, according to Malaz Boustani, M.D., MPH, of the Indiana University School of Medicine and the Regenstrief Institute, Inc. and colleagues from the University of Kent and the University of Cambridge in the United Kingdom in a commentary published in the Nov. 28 issue of the Journal of the American Medical Association.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.
› Verified 2 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, and Dialysis Corporation of America, a leading provider of outpatient kidney dialysis centers, announced today that they have entered into a definitive merger agreement for USRC to acquire DCA.
Primary care physicians should focus on "dementia red flags" rather than routinely screen individuals with no dementia symptoms just because they've reached a certain age, according to Malaz Boustani, M.D., MPH, of the Indiana University School of Medicine and the Regenstrief Institute, Inc. and colleagues from the University of Kent and the University of Cambridge in the United Kingdom in a commentary published in the Nov. 28 issue of the Journal of the American Medical Association.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glauco Radoslovich, MD 100 Winston Dr, 11cs, Cliffside Pk, NJ 07010-3240 Ph: (201) 224-9845 | Glauco Radoslovich, MD 20 Prospect Ave, Ste 701, Hackensack, NJ 07601-1997 Ph: (201) 996-2997 |
News Archive
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, and Dialysis Corporation of America, a leading provider of outpatient kidney dialysis centers, announced today that they have entered into a definitive merger agreement for USRC to acquire DCA.
Primary care physicians should focus on "dementia red flags" rather than routinely screen individuals with no dementia symptoms just because they've reached a certain age, according to Malaz Boustani, M.D., MPH, of the Indiana University School of Medicine and the Regenstrief Institute, Inc. and colleagues from the University of Kent and the University of Cambridge in the United Kingdom in a commentary published in the Nov. 28 issue of the Journal of the American Medical Association.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.
› Verified 2 days ago
Dr. Sean Shabbir Sadikot, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 707, Hackensack, NJ 07601 Phone: 551-996-2211 Fax: 551-996-5727 | |
Mr. Angel J Mulkay, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 493 Essex Avenue, Hackensack, NJ 07601 Phone: 201-996-9244 Fax: 201-601-0995 | |
Dr. Morris Samuel Friedman, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 1st St, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. David Serur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 406, Hackensack, NJ 07601 Phone: 551-996-2608 Fax: 551-996-0826 | |
Jerome F Levine, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, Suite 507, Hackensack, NJ 07601 Phone: 201-487-4088 | |
Dr. Noa Biran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-8704 Fax: 551-996-0582 | |
Naresh Chanderi, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 344 Prospect Ave, Hackensack, NJ 07601 Phone: 201-342-4233 Fax: 201-342-4840 |